Telesis Bio, Inc. logo

Telesis Bio, Inc.

NASDAQ:TBIO

Overview | Financials
Company Name Telesis Bio, Inc.
Symbol TBIO
Currency USD
Price 0.3
Market Cap 532,752
Dividend Yield 0%
52-week-range 0.25 - 10.062
Industry Medical Devices
Sector Healthcare
CEO Dr. Todd R. Nelson MBA, Ph.D.
Website https://codexdna.com

An error occurred while fetching data.

About Telesis Bio, Inc.

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online

Related Stocks

STAAR Surgical Company logo

STAAR Surgical Company

STAA

17.05 USD

LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc.

LFST

6.92 USD

Neogen Corporation logo

Neogen Corporation

NEOG

9.05 USD

Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc.

PCRX

22.87 USD

Denali Therapeutics Inc. logo

Denali Therapeutics Inc.

DNLI

15.15 USD

Progyny, Inc. logo

Progyny, Inc.

PGNY

20.36 USD

Roivant Sciences Ltd. logo

Roivant Sciences Ltd.

ROIV

10.66 USD

Certara, Inc. logo

Certara, Inc.

CERT

10.92 USD

Financials

Numbers are in millions USD

Numbers are in millions USD